Medicare covers deep brain stimulation (DBS) to treat Parkinson’s disease or essential tremor when a doctor deems it medically necessary and when a person meets the coverage criteria.

The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

Unable to speak because of a brain disorder known as spasmodic dysphonia, Susan O'Sullivan signed up for a clinical trial, ...

In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.

The Parkinson’s Foundation estimates that 15,000 people here in Wisconsin have Parkinson’s disease, and that number is only ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...